Latest Articles

Publication Date
Small cap wrap: Medicus Pharma, Tiziana Life Sciences, Namibia Critical Metals... - Proactive Investors

Small cap wrap: Medicus Pharma, Tiziana Life Sciences, Namibia Critical Metals... Proactive Investors

Published: July 31, 2026, 3:30 p.m.
Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial - Proactive financial news

Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial Proactive financial news

Published: July 31, 2026, 3:20 p.m.
Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial - Yahoo Finance UK

Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial Yahoo Finance UK

Published: July 31, 2026, 3:09 p.m.
Xpovio mulligan in endometrial cancer comes up short as Karyopharm presses on in myelofibrosis - Fierce Pharma

Xpovio mulligan in endometrial cancer comes up short as Karyopharm presses on in myelofibrosis Fierce Pharma

Published: July 31, 2026, 2 p.m.
Medicus Pharma gets UAE approval for Phase 2a t... - Pluang

Medicus Pharma gets UAE approval for Phase 2a t... Pluang

Published: July 31, 2026, 1:44 p.m.
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix - Yahoo! Finance Canada

Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix Yahoo! Finance Canada

Published: July 31, 2026, 1:24 p.m.
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix - ca.finance.yahoo.com

Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix ca.finance.yahoo.com

Published: July 31, 2026, 1:24 p.m.
Medicus Pharma gets UAE approval for Phase 2a p... - Pluang

Medicus Pharma gets UAE approval for Phase 2a p... Pluang

Published: July 31, 2026, 12:04 p.m.
Medicus Pharma receives UAE approval for endometriosis study - Investing.com

Medicus Pharma receives UAE approval for endometriosis study Investing.com

Published: July 31, 2026, 11:46 a.m.
Medicus Pharma Receives UAE IND Authorization for PRECISION-E2 Phase 2a Endometriosis Study of Teverelix - Quiver Quantitative

Medicus Pharma Receives UAE IND Authorization for PRECISION-E2 Phase 2a Endometriosis Study of Teverelix Quiver Quantitative

Published: July 31, 2026, 11:40 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!